PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $259,597 | +9.0% | 6,383 | +29.8% | 0.00% | 0.0% |
| Q1 2023 | $238,131 | -5.5% | 4,916 | -7.8% | 0.00% | 0.0% |
| Q1 2021 | $252,000 | -34.7% | 5,332 | -15.7% | 0.00% | -50.0% |
| Q4 2020 | $386,000 | -48.2% | 6,327 | -60.3% | 0.00% | -33.3% |
| Q3 2020 | $745,000 | -25.1% | 15,935 | -18.7% | 0.00% | -40.0% |
| Q2 2020 | $995,000 | +19.0% | 19,602 | +4.7% | 0.01% | 0.0% |
| Q1 2020 | $836,000 | +195.4% | 18,730 | +217.6% | 0.01% | +400.0% |
| Q4 2019 | $283,000 | +10.1% | 5,897 | +3.4% | 0.00% | 0.0% |
| Q2 2019 | $257,000 | -15.2% | 5,703 | -35.4% | 0.00% | -50.0% |
| Q4 2018 | $303,000 | -32.1% | 8,823 | -7.1% | 0.00% | 0.0% |
| Q3 2018 | $446,000 | +94.8% | 9,493 | -17.2% | 0.00% | +100.0% |
| Q3 2017 | $229,000 | – | 11,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |